Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for AREDIA
- 4-weekly Versus 12-weekly Administration of Bone-targeted Agents in Patients With Bone Metastases
- Evaluate Time Associated With the Preparation & Administration of Denosumab/Pamidronate in Patients With Solid Tumors and Metastatic Bone Disease
- Prevention of Bone Loss After Pediatric Hematopoietic Cell Transplantation
- Personalized Treatment Selection for Metastatic Breast Cancer
- Single Dosing of Zoledronic Acid in Cancer Therapy Induced Bone Loss (CTIBL)
- Efficacy of Pamidronate in the Treatment of Bone Loss Associated With Liver Transplant
- Prevention of Post Operative Bone Loss in Children
- Samarium Sm 153 Lexidronam Pentasodium Combined With Zoledronic Acid or Pamidronate in Treating Patients With Relapsed or Refractory Multiple Myeloma and Bone Pain
- Toulouse Male Long Term Bed Rest 2001-2002
- Pamidronate Administration in Breast Cancer Patients With Bone Metastases
- Arsenic Trioxide and Pamidronate in Treating Patients With Advanced Solid Tumors or Multiple Myeloma
- Vitamin K and Bone Turnover in Postmenopausal Women
Clinical trials list
click for details